FE Measure/ activity | Measure/activity description | Develop-mental | Impl./ progress focused | Interpret./ sustainability focused |
---|---|---|---|---|
Reach/Implementation Analysis | ||||
Referral rates | Number of patients referred on weekly and monthly basis. | Â | X | X |
Treatment uptake | Percent of referred patients enrolling in treatment, engaging in treatment, and completing treatment. | Â | X | X |
Exposure to TeleQuitMH | Percent of MH patients for whom tobacco use screening was completed. | Â | Â | X |
Patient Process Data | ||||
Enrollment Rates | Rates of enrollment to TeleQuit MH and State quitlines | Â | X | X |
TeleQuitMH Satisfaction | Self-reported satisfaction with TeleQuitMH structure and treatment (including VA versus quitline satisfaction) ; assessed 2m and 6m after enrolling | Â | X | X |
Provider Process Data | ||||
Provider Survey | Perceptions of program marketing; how likely they will be to use the program; barriers to implementation; suggestions for improvement; provider use of the program; program satisfaction; perceived effectiveness of activities to facilitate implementation; impact of the program on their patients/client. | X | X | X |
Stakeholder Interviews | Perceptions of program marketing; how likely they will be to use the program; barriers to implementation; suggestions for improvement; provider use of the program; likes/dislikes about the program; impact of the program on their patients/clients. | X | X | X |
Referral rates/patterns | Percent of providers referring; Number of referrals from each provider; Rates by provider type | Â | X | X |
MH Unit Data on Implementation Context | Â | Â | Â | |
VA Survey of MH Programs[28] | Clinic’s structure, size, staffing, environment, and resources for meeting MH and tobacco cessation treatment goals. |  |  | X |
MH Unit Performance Data[29] | Clinic-level performance on VA MH and tobacco performance measures | Â | Â | X |
Implementation Facilitation - Structure | ||||
Site Champion | Presence of a site champion, level of interest in performing site champion duties, position at the VA, role on the project | X | X | X |
Site Clinical Advisory Committee | Presence of a site Clinical Advisory Committee, level of interest in performing Committee duties, Committee members positions at the VA & roles on the project | X | X | X |
Site smoking cessation services | Presence, types, and structure of site smoking cessation clinic and other local smoking cessation services | X | Â | X |
TeleQuitMH Structure | Structure of the TeleQuitMH program at each site, including design and appearance of the tobacco cessation clinical reminder, prescribing structure, and referral mechanisms (e.g., consult design, email referral option) | X | X | X |
State quitline Structure/Issues | Structure of quitline services; issues/problems identified in connecting TeleQuitMH patients to quitline services. | X | X | X |
IRB Issues | Time from first submission to receiving IRB approval; type of submission required (full board review, expedited, exempt); site-specific requirements that may affect TeleQuitMH implementation and adoption (e.g., detailed consent process) | X | Â | X |
Implementation Facilitation - Activities | ||||
Marketing Efforts | Provider outreach efforts, academic detailing, provider feedback. | Â | X | X |
Treatment Fidelity | Extent to which the TeleQuitMH staff are providing the telephone counseling, medication coordination and warm-transfer to the state quitlines as intended. | Â | X | X |